2,2,5,7,8-pentamethyl-1-hydroxychroman has been researched along with Colonic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J; Jang, Y; Jiang, Q; Park, NY; Rostgaard-Hansen, AL | 1 |
1 other study(ies) available for 2,2,5,7,8-pentamethyl-1-hydroxychroman and Colonic Neoplasms
| Article | Year |
|---|---|
Vitamin E metabolite 13'-carboxychromanols inhibit pro-inflammatory enzymes, induce apoptosis and autophagy in human cancer cells by modulating sphingolipids and suppress colon tumor development in mice.
Topics: Animals; Apoptosis; Arachidonate 5-Lipoxygenase; Autophagy; Chromans; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Garcinia kola; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mice; Sphingolipids; Tocopherols; Vitamin E | 2016 |